Clal Biotechnology reported ILS39.53M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 1.34B 1.1B Aug/2026
Bio Path USD 0 1000K Aug/2026
Brainstorm Cell Therapeutics USD 43M 32M Aug/2026
Cara Therapeutics USD 110M 80M Aug/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 1000K 4M Jul/2026